Farag, Dr. Hosam
About
Dr. Farag is a medical Doctor, research scientist, and public health professional specializing in epidemiology, infectious diseases, and kidney diseases. He teaches various epidemiology, public health, and microbiology courses at Carolina University. Dr. Farag's expertise lies in designing and analyzing epidemiological research studies. His research interests primarily revolve around preventive medicine and the early detection of diseases, utilizing biomarkers and predictive models to identify high-risk patients across various care settings, including outpatient, inpatient, and post-hospital care. He is particularly passionate about the efficient utilization of large datasets within a multidisciplinary framework to enhance the quality of healthcare systems and alleviate the economic burden.
Dr. Farag has established successful collaborations with prominent entities such as IBM Watson to develop and validate a machine-learning algorithm to predict inpatient mortality of sepsis. The success of this endeavor garnered national recognition from the media, and Dr. Farag had the privilege of being a speaker at the prestigious IBM THINK conference in 2019, held in San Francisco, CA. Additionally, he partnered with the La Jolla pharmaceutical company to conduct a clinical trial aimed at treating septic patients. Dr. Farag's collaboration with the Centers for Disease Control and Prevention (CDC) involved a serology study focused on the treatment of COVID-19 patients.
As a Co-Principal Investigator for multiple clinical trials, Dr. Farag validated systems like Accelerate Pheno and BioFire FilmArray for organism identification and evaluated the Sysmex analyzer for cellular sepsis alerts. Recently, Dr. Farag served as a Principal Investigator (PI) in a study that focused on the novel maximum partial Sequential Organ Failure Assessment (SOFA) score at six hours, laboratory biomarkers, and clinical data to predict organ dysfunction and severity in COVID-19 patients. These research efforts reflect Dr. Farag's dedication to advancing medical knowledge and improving patient outcomes.
Dr. Farag actively participated in initiatives like Clinical Laboratory 2.0 to assess clinical laboratories in American healthcare. As a skilled team leader, He builds and validates laboratory core datasets for sepsis in multisite health systems and engages in educational series, microbiology rounds, infectious diseases case conferences, and clinical rotations in pediatric and adult Infectious Diseases.
Dr. Farag has more than ten years of teaching experience with undergraduate and graduate students, residents, and fellows. He serves as an academic advisor with excellent teaching ratings.
